Literature DB >> 15348058

Porous ceramic bodies for drug delivery.

A Krajewski1, A Ravaglioli, E Roncari, P Pinasco, L Montanari.   

Abstract

An approach to the production of ceramic drug delivery devices is proposed. Two examples of possible ceramics are dealt with: hydroxyapatite weakly modifiable by living tissue and the bioinert alumina. The possibility to control the formed porosity was taken into consideration for both materials. The ratio between the acquired porosity and the quantity and quality of the agents inducing porosity is also described and discussed. A test on the role of porosity was performed on the obtained porous ceramic bodies and a study was made on the release of a substance with pharmacological activity from previously impregnated porous ceramic bodies. This paper is preliminary to a planned work targeted to the preparation of ceramic drug delivery systems. Copyright 2000 Kluwer Academic Publishers

Entities:  

Year:  2000        PMID: 15348058     DOI: 10.1023/a:1008988127294

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  1 in total

1.  Net-shaped hydroxyapatite implants for release of agents modulating periodontal-like tissues.

Authors:  H Denissen; E van Beek; R Martinetti; C Klein; E van der Zee; A Ravaglioli
Journal:  J Periodontal Res       Date:  1997-01       Impact factor: 4.419

  1 in total
  8 in total

1.  Porous hydroxyapatite ceramics of bi-modal pore size distribution.

Authors:  V S Komlev; S M Barinov
Journal:  J Mater Sci Mater Med       Date:  2002-03       Impact factor: 3.896

2.  Synthesis and hydrothermal treatment of nanostructured hydroxyapatite of controllable sizes.

Authors:  Say Chye Joachim Loo; Yiwei Eva Siew; Shuhui Ho; Freddy Yin Chiang Boey; J Ma
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

3.  Effects of calcination temperature on the drug delivery behaviour of Ibuprofen from hydroxyapatite powders.

Authors:  Amanda J Melville; Luis M Rodríguez-Lorenzo; John S Forsythe
Journal:  J Mater Sci Mater Med       Date:  2007-08-15       Impact factor: 3.896

4.  Comparison of three dissolution apparatuses for testing calcium phosphate pellets used as ibuprofen delivery systems.

Authors:  Emilie Chevalier; Marylène Viana; Aymeric Artaud; Lisette Chomette; Samir Haddouchi; Gille Devidts; Dominique Chulia
Journal:  AAPS PharmSciTech       Date:  2009-05-14       Impact factor: 3.246

Review 5.  Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds.

Authors:  Viviana Mouriño; Aldo R Boccaccini
Journal:  J R Soc Interface       Date:  2009-10-28       Impact factor: 4.118

6.  Development of new localized drug delivery system based on ceftriaxone-sulbactam composite drug impregnated porous hydroxyapatite: a systematic approach for in vitro and in vivo animal trial.

Authors:  Biswanath Kundu; Chidambaram Soundrapandian; Samit K Nandi; Prasenjit Mukherjee; Nandadulal Dandapat; Subhasis Roy; Bakul K Datta; Tapan K Mandal; Debabrata Basu; Rupnarayan N Bhattacharya
Journal:  Pharm Res       Date:  2010-05-13       Impact factor: 4.200

7.  Influence of hydrothermal synthesis parameters on the properties of hydroxyapatite nanoparticles.

Authors:  Sylwia Kuśnieruk; Jacek Wojnarowicz; Agnieszka Chodara; Tadeusz Chudoba; Stanislaw Gierlotka; Witold Lojkowski
Journal:  Beilstein J Nanotechnol       Date:  2016-11-04       Impact factor: 3.649

8.  In vivo evaluation of a novel nanocomposite porous 3D scaffold in a rabbit model: histological analysis.

Authors:  Saffanah Khuder Mahmood; Intan-Shameha Abdul Razak; Mustafa Saddam Ghaji; Loqman Mohamed Yusof; Zaid Khudhur Mahmood; Mohd Adha Bin P Rameli; Zuki Abu Bakar Zakaria
Journal:  Int J Nanomedicine       Date:  2017-12-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.